Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Ottawa

$27,000.00

Investigating the Biological and Neurobiological Link Between PCOS and Depression for Therapeutic Interventions

EF 2024-25

Résumé
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder affecting women of reproductive age worldwide. Beyond its physical symptoms, PCOS is strongly associated with mental health challenges, with over 40% of women diagnosed with PCOS also experiencing depression. Despite this significant link, the mechanisms connecting PCOS and depression remain poorly understood, and effective treatments addressing both conditions are limited. Emerging research highlights the role of neurosteroids, such as allopregnanolone (ALLO), in managing depression. ALLO regulates key brain chemicals involved in mood and behaviour and influences ovarian function, making it a promising candidate for treating both the psychiatric and reproductive symptoms of PCOS.This study aims to explore the connection between PCOS and depression using two established mouse models that replicate PCOS symptoms through exposure to dehydroepiandrosterone (DHEA) or letrozole. The research will assess how these models influence depression-like behaviours and biological markers associated with mood disorders. By comparing the two models, the study seeks to develop a reliable PCOS-depression mouse model for future testing of therapeutic interventions, including neurosteroids like ALLO.This research will advance understanding of how PCOS contributes to depression and facilitate the development of treatments that improve both mental and reproductive health outcomes for women with PCOS. Furthermore, the findings have the potential to benefit a broader population affected by depression, extending the impact beyond those with PCOS.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
530186
Name
Dubé-Zinatelli Eleni
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the Biological and Neurobiological Link Between PCOS and Depression for Therapeutic Interventions
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Depression; Endocrine Disorders; Gynecology; Hormonal Dysregulation; Hyperandrogenism; Mental Health; Neuroendocrinology; Polycystic Ovary Syndrome (Pcos); Reproductive Health; Women'S Health
Abstract
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder affecting women of reproductive age worldwide. Beyond its physical symptoms, PCOS is strongly associated with mental health challenges, with over 40% of women diagnosed with PCOS also experiencing depression. Despite this significant link, the mechanisms connecting PCOS and depression remain poorly understood, and effective treatments addressing both conditions are limited. Emerging research highlights the role of neurosteroids, such as allopregnanolone (ALLO), in managing depression. ALLO regulates key brain chemicals involved in mood and behaviour and influences ovarian function, making it a promising candidate for treating both the psychiatric and reproductive symptoms of PCOS.This study aims to explore the connection between PCOS and depression using two established mouse models that replicate PCOS symptoms through exposure to dehydroepiandrosterone (DHEA) or letrozole. The research will assess how these models influence depression-like behaviours and biological markers associated with mood disorders. By comparing the two models, the study seeks to develop a reliable PCOS-depression mouse model for future testing of therapeutic interventions, including neurosteroids like ALLO.This research will advance understanding of how PCOS contributes to depression and facilitate the development of treatments that improve both mental and reproductive health outcomes for women with PCOS. Furthermore, the findings have the potential to benefit a broader population affected by depression, extending the impact beyond those with PCOS.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Dubé-Zinatelli, Eleni
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~